AHR American Healthcare REIT, Inc. - Fundamental Analysis
BEARISH
Sign in to save
Save this symbol to a watchlist or track a position.
AHR Stock | Fundamental Analysis & Investment Insights
NYSE
Real Estate
REIT - Healthcare Facilities
Current Price
Live
$46.24
Analyst Target
$56.0
+21.1%
Upside
52W High
$51.02
52W Low
$26.48
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Jan 24, 2026
Market cap
$8.61B
P/E
385.33
ROE
1.1%
Profit margin
1.2%
Debt/Equity
0.62
Dividend yield
2.15%
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
78%
Analysis Accuracy
The deterministic health scores raise significant concerns, with a Piotroski F-Score of 4/9 indicating marginal financial stability and no available Altman Z-Score to confirm solvency. Despite strong recent price performance and a bullish analyst recommendation, the stock trades at extreme valuation multiples (P/E of 385 and Forward P/E of 65), far above sector averages, while profitability remains weak (ROE: 1.10%, ROA: 2.15%). The dividend is dangerously overfunded with an 833% payout ratio, and insider activity is uniformly bearish, with $3.88M in net sales over the past six months. Although revenue growth and recent earnings surprises are positive, these do not justify the current premium given underlying financial fragility.
Key Strengths
Strong revenue growth (9.9% YoY) outpaces some peers in the REIT - Healthcare Facilities sector
Recent quarterly earnings show dramatic year-over-year EPS growth (+2600%) and strong average surprise (+66.47%) over last four quarters
Analyst consensus is 'buy' with a $56.00 target price, implying 21% upside
Current ratio (1.53) and quick ratio (1.23) suggest adequate short-term liquidity
Debt/Equity of 0.62 is well below sector average of 3.91, indicating conservative leverage
Key Risks
Piotroski F-Score of 4/9 indicates weak financial health, particularly concerning for a REIT dependent on stable cash flows
Extremely high P/E ratio (385) and Forward P/E (65) suggest severe overvaluation relative to earnings
Dividend payout ratio of 833% is unsustainable and poses high risk of cut or suspension
Insider selling of $3.88M in the last six months signals lack of confidence from corporate insiders
Profitability metrics are weak: ROE (1.10%) and ROA (2.15%) are well below sector benchmarks despite positive revenue trends
AI Fair Value Estimate
Based on comprehensive analysis
$6.5
-85.9% below current price
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
40
Moderate
22
68
54
38
18
AI Verdict
Overvalued with fragile fundamentals despite growth momentum
Key drivers: High P/E and Forward P/E, Low Piotroski F-Score, Unsustainable dividend payout, Strong insider selling, Extreme valuation vs. weak profitability
Confidence
82%
Value
22/100
Ref P/E, PEG, Graham Number
Positives
- Price/Book of 2.95 is below sector average of 3.91
- Debt/Equity is low at 0.62
Watchpoints
- P/E of 385.33 is extremely high
- Forward P/E of 65.13 remains elevated
- Graham Number ($6.50) implies severe overvaluation at $46.24
Future
68/100
Ref Growth rates
Positives
- Revenue growth of 9.9% YoY
- Most recent Q/Q EPS growth of +350%
- YoY EPS growth of +2600%
- Analyst target suggests 21% upside
Watchpoints
- No PEG ratio due to unreliable earnings base
- Earnings growth not yet consistent
Past
54/100
Ref Historical trends
Positives
- 5Y price return of +278.7%
- 1Y return of +65.4%
- Mixed but improving earnings beat record (2 of last 4 quarters)
Watchpoints
- High volatility in earnings surprises (from -45.5% to +170%)
- Negative EPS in prior quarters
Health
38/100
Ref Altman Z-Score, Piotroski F-Score
Positives
- Current ratio of 1.53 indicates short-term solvency
- Quick ratio of 1.23 shows liquid asset coverage
Watchpoints
- Piotroski F-Score of 4/9 indicates weak financial health
- No Altman Z-Score available for distress assessment
- ROE (1.10%) and ROA (2.15%) are very low
Dividend
18/100
Ref Yield, Payout
Positives
- Dividend yield of 2.15% provides modest income
Watchpoints
- Payout ratio of 833.33% is dangerously high
- Dividend Strength score of 20/100 indicates high risk
- No 5-year average yield to assess consistency
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$46.24
Analyst Target
$56.0
Upside/Downside
+21.1%
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for AHR and closest competitors.
Updated 2026-01-23
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
AHR
American Healthcare REIT, Inc.
Primary
|
+278.7% | +278.7% | +65.4% | +25.2% | -4.0% | -3.7% |
|
AGNCN
AGNC Investment Corp.
Peer
|
+58.3% | +38.4% | +9.9% | +4.4% | +0.7% | -0.4% |
|
ADC
Agree Realty Corporation
Peer
|
+38.9% | +12.4% | +5.9% | +0.8% | +0.6% | -0.9% |
|
AGNCM
AGNC Investment Corp.
Peer
|
+50.4% | +45.5% | +8.3% | +3.6% | +0.6% | -0.2% |
|
BRX
Brixmor Property Group Inc.
Peer
|
+90.8% | +33.3% | +5.2% | +5.4% | +1.4% | -1.0% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
385.33
Forward P/E
65.13
PEG Ratio
N/A
P/B Ratio
2.95
P/S Ratio
3.93
EV/Revenue
4.46
EV/EBITDA
26.05
Market Cap
$8.61B
Profitability
Profit margins and return metrics
Profit Margin
1.24%
Operating Margin
7.5%
Gross Margin
18.05%
ROE
1.1%
ROA
2.15%
Growth
Revenue and earnings growth rates
Revenue Growth
+9.9%
Earnings Growth
N/A
Q/Q Revenue Growth
N/A
Q/Q Earnings Growth
N/A
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
0.62
Moderate
Current Ratio
1.53
Good
Quick Ratio
1.23
Good
Cash/Share
$0.83
Quarterly Earnings History
EPS performance vs analyst estimates
2026-02-26
$N/A
2025-11-06
$0.27
+74.8% surprise
2025-08-07
$0.06
-45.5% surprise
2025-05-08
$0.11
+170.0% surprise
Real Estate Sector Comparison
Comparing AHR against 56 companies in the Real Estate sector
(1 bullish, 9 neutral, 46 bearish)
P/E Ratio
385.33
This Stock
vs
49.55
Sector Avg
+677.6%
(Expensive)
Return on Equity (ROE)
1.1%
This Stock
vs
-75.18%
Sector Avg
-101.5%
(Below Avg)
Profit Margin
1.24%
This Stock
vs
26.43%
Sector Avg
-95.3%
(Weaker)
Debt to Equity
0.62
This Stock
vs
3.27
Sector Avg
-80.9%
(Less Debt)
Revenue Growth
9.9%
This Stock
vs
1431.44%
Sector Avg
-99.3%
(Slower)
Current Ratio
1.53
This Stock
vs
3449.18
Sector Avg
-100.0%
(Weaker)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
AHR
American Healthcare REIT, Inc.
|
BEARISH | $8.61B | 385.33 | 1.1% | 1.2% | $46.24 | |
|
AGNCN
AGNC Investment Corp.
|
BEARISH | $8.83B | - | 15.1% | 92.9% | $25.72 | |
|
ADC
Agree Realty Corporation
|
NEUTRAL | $8.36B | 42.18 | 3.5% | 28.1% | $72.55 | |
|
AGNCM
AGNC Investment Corp.
|
BEARISH | $8.88B | - | 15.1% | 92.9% | $24.98 | |
|
BRX
Brixmor Property Group Inc.
|
BEARISH | $8.08B | 24.23 | 11.4% | 24.7% | $26.41 |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-23 | HANSON JEFFREY T. | Director | Sale | 54,778 | $2,650,400 |
| 2025-11-11 | FOSTER MARK E. | General Counsel | Sale | 1,500 | $74,030 |
| 2025-11-10 | HANSON JEFFREY T. | Director | Sale | 20,010 | $994,105 |
| 2025-09-03 | FOSTER MARK E. | General Counsel | Sale | 3,850 | $161,271 |
Insider transactions can signal confidence or concerns about company prospects
Wall Street Analysts
Professional analyst ratings and price targets
Consensus
BUY
12 analysts
Truist Securities
2026-01-20
Buy
Buy
Truist Securities
2025-11-26
Buy
Buy
Citigroup
2025-11-21
Neutral
Neutral
Morgan Stanley
2025-11-20
Overweight
Overweight
UBS
2025-11-17
Buy
Buy
Scotiabank
2025-11-13
Sector Outperform
Sector Outperform
Keybanc
2025-11-13
Overweight
Overweight
RBC Capital
2025-11-12
Outperform
Outperform
Citizens
2025-11-10
Market Outperform
Market Outperform
JMP Securities
2025-10-17
Market Outperform
Market Outperform
Past News Coverage
Recent headlines mentioning AHR from our newsroom.
Newest → oldest
No matching news yet.